73
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Silver nanoparticles increase cytotoxicity induced by intermediate frequency low voltages

, , , &
Pages 317-321 | Received 16 Oct 2013, Accepted 31 Mar 2014, Published online: 05 Jun 2014
 

Abstract

Electrical properties of the cells play a key role in biological processes. Intermediate frequencies of electrical fields influence the cells proliferation without heat generation and electrical stimulation. Silver nanoparticle (SNP) as a metallic agent can change the electrical characteristics of the cells. We study the effect of low voltages at an intermediate frequency (300 kHz) on a human breast adenocarcinoma cell line (MCF7) in the presence of SNPs. At first, cell toxicity of SNPs was determined at different concentrations. Then three different voltages were applied to the cells for 15 min, both in the presence and absence of SNPs. The treatments efficiency was evaluated by MTT assay. The results showed that the intermediate frequency-low voltages with SNPs not only provide an additive efficacy on cytotoxicity, but also a synergism was observed between these factors. By increasing the voltage from 3 to 9 V, a rising synergistic rate was observed. It seems that the synergistic effect between SNPs and the 300 kHz low voltages can inhibit cell proliferation and/or increases cell death of MCF-7, and hence increases treatment efficiency of SNPs, effectively.

Acknowledgements

We thank Mr. Ali Ehtesham for design and parameters confirming of the medium frequency generator used in this project. This paper has been extracted from a MSc thesis of medical physics.

Declaration of interest

The authors report no conflicts of interest.

They also appreciate the research deputy of Mashhad University of Medical Sciences for financial support of the project.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.